Born 1980. Active in the company since 2006. Anna Ljung has more than 20 years of experience in the pharmaceutical industry, including as CFO of other biotech companies such as Athera Biotechnologies AB and Lipopetide AB and as independent technology licensing consultant. In addition to serving as CEO of Moberg Pharma, she also currently serves as Chair of Biosergen AB and as a Board member of Saniona AB.
Shareholding: 89 499 shares and 414 792 performance share units that can entitle a maximum of 414 792 shares.
Born in 1963. Has worked for the company since 2013. Annica Magnusson is a pharmacist with more than 20 years of experience in international work within the pharmaceutical industry and Regulatory Affairs at AstraZeneca. Annica Mangusson has worked with the development and registration of pharmaceuticals, vaccines and medical devices in the EU, USA, Japan with several markets.
Shareholding: 58 462 shares and 248 874 performance share units that can entitle a maximum of 248 874 shares.
Born in 1975.Has worked for the company since 2026. Helena Jansson has more than 30 years of experience from leading positions in business management, business development and commercialization within life sciences. Helena has led global marketing, sales, and commercial operations which will add extensive cross-functional leadership experience and a proven track record in creating long-term partnerships and delivering growth to the company. Most recently, Helena held the position as Managing Director at Palette Life Sciences AB and has previously been responsible for the commercial portfolios of BioPhausia AB and Medivir AB.
Shareholding: 0 shares and 41 479 performance share units that can entitle a maximum of 41 479 shares.
Born 1978. B. Com, GradDipCA. Active in the company since 2015. Mark Beveridge has more than 15 years of experience as an advisor in accounting, insurance and auditing, primarily from Crowe Horwath and Visma Services. Mark has also worked as an independent consultant within financial control, transaction consultancy and implementation of business systems. Mark is a Board member at Loaded Dice AB.
Shareholding: 100 132 shares and 312 958 performance share units that can entitle a maximum of 216 079 shares.
Born in 1966. Has worked for the company since 2026.Vaidrius Navikas has more than 30 years of global experience in pharmaceutical development and commercialization. Prior to joining Moberg Pharma, he held positions at several pharmaceutical companies and academic institutions, most recently as Head of Global Medical Affairs at H. Lundbeck A/S. Vaidrius has extensive experience in clinical development, medical affairs, regulatory strategy, and scientific engagement.
Shareholding: 0 shares and 41 479 performance share units that can entitle a maximum of 41 479 shares.
Current shareholding is not automatically updated for the moment. Insiders no longer have obligation to report there shareholding. According to the regulatory requirements, the data shall be updated once a year.